Replies to post #3059 on Biomoda Inc. (fka BMODQ)

[The Rainmaker]

Ohio part 2: (MOU) to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda's porphyrin-based assay for the detection of early-stage cancer.

Expand our strategic alliance with Obio to include operational facilities.

Obio, Inc., a corporation formed to pursue public and private funding for cancer research in Ohio, are working together to expand Biomoda’s lung cancer screening program for veterans into Ohio.

Obio gives Biomoda a presence in a state that is recognized as a leader in cancer research and treatment. Ohio’s leaders have established programs and funding to attract promising biomedical technologies to the state through innovative public initiatives that support both research and commercialization,

Obio will help Biomoda launch a veterans screening program in Ohio, similar to ones completed in New Mexico and under consideration by the Nebraska Legislature.

Also identifying sites for the upcoming Phase III trials, and Ohio is home to several world-class comprehensive cancer centers.”

[rocketeer357]

I suspect successful publication of phase 2 results will go a long way to opening up state coffers for further studies. In the past, BMOD has spoken confidently of getting money from states.

Phase 2 as hoped for puts everything back on track. Interesting that we're trading in an almost identical channel to the last time phase 2 results were pending. This time, I'm betting Maire gets it right.